Our study suggests that the glycosaminoglycan heparan sulfate and the glycoproteins ICAM-1, VCAM-1, and E-selectin are significantly increased in the plasma of sepsis patients with cognitive impairment. Here, ICAM1 is linked to Cognitive impairment.